Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Ann Surg. 2018 Oct;268(4):632–639. doi: 10.1097/SLA.0000000000002955

Table 3:

Post-surgery survival by surveillance intensity in patients alive and disease free 9 months post-surgery.

HR (95% CI) p-value
Surveillance group: 3-month (reference) 0.091
 6-month 1.12 (0.98, 1.29)
Histology: Adenocarcinoma (reference) 0.991
 Squamous 0.99 (0.86, 1.14)
 Other histology 1.00 (0.80, 1.26)
Surgery: Lobectomy (reference) 0.010
 Pneumonectomy 0.95 (0.70, 1.30)
 Segmentectomy 1.39 (0.86, 2.26)
 Wedge resection 1.34 (1.12, 1.60)
Any chemotherapy 1.01 (0.86, 1.20) 0.976
Any radiation 1.39 (1.11, 1.72) < 0.001
Age (per decade) 1.23 (1.12, 1.36) < 0.001
Sex: Male (reference) 0.011
 Female 0.84 (0.73, 0.96)
Chronic obstructive pulmonary disease 1.17 (1.00, 1.37) 0.054
Congestive heart failure 1.50 (1.14, 1.97) 0.003
Coronary artery disease 1.11 (0.94, 1.31) 0.215
Diabetes 1.07 (0.90, 1.29) 0.435
Peripheral vascular disease 1.37 (1.09, 1.72) 0.007
Psychiatric 1.20 (0.95, 1.51) 0.133
Substance abuse 1.32 (1.03, 1.70) 0.029